IL-17 was shown to stimulate in vitro the growth of ovarian cancer tumorspheres initiated by CD133+ cells through stimulation of the IL-17 receptor present on the surface of these cells [247]. This evidence concerns the gene PROM1 and ovarian carcinoma.